Sign in

CIK 0001598646

  • Non-accelerated filer
  • Smaller reporting company

Minerva Neurosciences, Inc.

Sign in to watch
Ticker
NERV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
260784194
Phone
+1 617-600-7373
Business address
1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market buy EVP and CFO bought 33,333 shares at $6.00 ($199,998)
  3. 4 Open-market buy Chief Accounting Officer bought 10,000 shares at $6.00 ($60,000)
  4. 4 Open-market buy Director bought 1,620,833 shares at $6.00 ($9,724,998)
  5. 4 Open-market buy 10% owner bought 1,620,833 shares at $6.00 ($9,724,998)
  6. 4 Open-market buy Director bought 1,620,833 shares at $6.00 ($9,724,998)
  7. 4 Open-market buy Chief Business Officer bought 8,333 shares at $6.00 ($49,998)
  8. 4 Open-market buy Director bought 3,333 shares at $6.00 ($19,998)
  9. 4 Open-market buy Director bought 737,500 shares at $6.00 ($4,425,000)
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy 10% owner bought 737,500 shares at $6.00 ($4,425,000)
  12. 4 Open-market buy President and CEO bought 41,667 shares at $6.00 ($250,002)
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 13 of 14 · 264 filings